Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Cell cultures, whether or not modified: > Other
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.59.00.00
Human Mesenchymal Stem Cell Culture
This product consists of human mesenchymal stem cells cultured in a nutrient medium for therapeutic applications in regenerative medicine, such as treating joint injuries or autoimmune diseases. It falls under HTS 3002.59.00.00 as 'other cell cultures, whether or not modified,' prepared for therapeutic uses via biotechnological processes. These cultures are not yeasts and are used directly in patient treatments.
Human Neural Progenitor Cell Culture
Progenitor cells from human neural tissue expanded in culture for neurodegenerative disease therapies like Parkinson's. Classified in HTS 3002.59.00.00 as other cell cultures modified biotechnologically for therapeutic uses. Used in stem cell transplants.
Human Keratinocyte Cell Culture
Epidermal keratinocytes cultured for skin graft therapies in burn treatment and wound healing. Falls under HTS 3002.59.00.00 as other human cell cultures for therapeutic uses. Biotechnologically expanded for clinical application.
Porcine Islet Cell Culture
Pancreatic islet cells from pigs cultured for xenotransplantation in diabetes treatment. Under HTS 3002.59.00.00 as other animal cell cultures for therapeutic, prophylactic uses. Addresses insulin-dependent diabetes.
iPSC-Derived Cardiomyocyte Cell Line
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. Classified under HTS 3002.59.00.00 as modified cell cultures for therapeutic uses, obtained through biotechnological reprogramming. These are used in clinical trials for heart disease treatments.
Primary Human Hepatocyte Cell Culture
Freshly isolated primary hepatocytes from human liver tissue, cultured for drug metabolism studies and liver failure therapies. This product is under HTS 3002.59.00.00 as other cell cultures prepared for therapeutic, prophylactic, or diagnostic uses. It supports hepatocyte transplantation and toxicology testing.
Murine T-Cell Hybridoma Culture
Hybridoma cell lines from mouse T-cells cultured for producing immunological products like cytokines in cancer immunotherapy. Falls under HTS 3002.59.00.00 as other animal cell cultures, whether modified, for therapeutic uses. These support monoclonal antibody production.
Vero Cell Culture for Vaccine Production
African green monkey kidney (Vero) cells cultured as substrate for growing viruses in vaccine manufacturing. Under HTS 3002.59.00.00 as other cell cultures for therapeutic vaccine production uses. Essential for polio and Ebola vaccines.
CHO Cell Culture for Protein Expression
Chinese hamster ovary (CHO) cells genetically modified and cultured for recombinant therapeutic protein production like insulin analogs. HTS 3002.59.00.00 covers these as other modified cell cultures for therapeutic uses. Widely used in biopharma.
HEK293 Cell Culture
Human embryonic kidney 293 (HEK293) cells cultured for viral vector production in gene therapy. Classified HTS 3002.59.00.00 as other modified cell cultures for therapeutic gene delivery uses. Key in AAV vector manufacturing.